Notify me when Samsara BioCapital, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 21 | $969,256,994 | +$134,556,048 | -$84,702,604 | +$49,853,444 | SRRK, MLYS, KLRS, SEPN, ALMS | 13F-HR | 17 Feb 2026, 16:44 |
| Q3 2025 | 27 | $765,928,969 | +$46,601,155 | -$46,457,234 | +$143,921 | MLYS, SRRK, KLRS, SEPN, NGNE | 13F-HR | 14 Nov 2025, 16:29 |
| Q2 2025 | 29 | $488,945,395 | +$16,473,605 | -$53,350,251 | -$36,876,646 | SRRK, MLYS, SEPN, KLRS, NGNE | 13F-HR | 14 Aug 2025, 16:44 |
| Q1 2025 | 37 | $560,764,410 | +$106,474,534 | -$60,634,871 | +$45,839,663 | SRRK, KLRS, MLYS, NGNE, ALMS | 13F-HR | 15 May 2025, 16:14 |
| Q4 2024 | 43 | $728,583,411 | +$130,157,383 | -$80,117,036 | +$50,040,347 | SRRK, CRGX, SEPN, MLYS, NGNE | 13F-HR | 14 Feb 2025, 17:17 |
| Q3 2024 | 42 | $520,276,874 | +$41,405,755 | -$18,822,015 | +$22,583,740 | CRGX, MLYS, SRRK, NGNE, ALMS | 13F-HR | 14 Nov 2024, 16:15 |
| Q2 2024 | 40 | $477,799,472 | +$56,990,876 | -$32,333,116 | +$24,657,760 | CRGX, MLYS, SRRK, NGNE, ACLX | 13F-HR | 14 Aug 2024, 16:17 |
| Q1 2024 | 39 | $646,373,019 | +$67,818,107 | -$149,835,814 | -$82,017,707 | SRRK, CRGX, MLYS, NGNE, NKTX | 13F-HR | 15 May 2024, 16:16 |
| Q4 2023 | 41 | $642,800,728 | +$179,343,330 | -$38,585,278 | +$140,758,052 | SRRK, RYZB, CRGX, MLYS, ACLX | 13F-HR | 14 Feb 2024, 16:29 |
| Q3 2023 | 41 | $326,684,744 | +$60,325,272 | -$225,961,513 | -$165,636,241 | MLYS, RYZB, SRRK, SLRN, ACLX | 13F-HR | 14 Nov 2023, 16:15 |
| Q2 2023 | 47 | $569,734,207 | +$53,158,126 | -$62,456,590 | -$9,298,464 | KDNY, MLYS, SLRN, SRRK, GRPH | 13F-HR | 14 Aug 2023, 16:58 |
| Q1 2023 | 56 | $483,843,138 | +$99,328,069 | -$20,515,796 | +$78,812,273 | KDNY, MLYS, SRRK, ACLX, GRPH | Restatement | 14 Aug 2023, 16:57 |
| Q4 2022 | 1 | $3,164,406 | $0 | $0 | $0 | SYRS | New Holdings | 15 Feb 2023, 17:03 |
| Q4 2022 | 54 | $464,406,176 | +$26,920,746 | -$69,601,662 | -$42,680,916 | KDNY, SRRK, ACLX, GRPH, VRNA | 13F-HR | 14 Feb 2023, 16:43 |
| Q3 2022 | 55 | $428,436,000 | $0 | -$30,461,096 | -$30,461,096 | KDNY, NKTX, SRRK, GRPH, FMTX | 13F-HR | 14 Nov 2022, 16:03 |
| Q2 2022 | 56 | $373,940,000 | +$71,301,652 | -$13,680,927 | +$57,620,725 | KDNY, NKTX, SRRK, GRPH, ACLX | 13F-HR | 15 Aug 2022, 16:00 |
| Q1 2022 | 56 | $395,488,000 | +$48,698,682 | -$4,919,232 | +$43,779,450 | KDNY, GRPH, NKTX, TIL, ISEE | 13F-HR | 16 May 2022, 16:13 |
| Q4 2021 | 49 | $501,995,000 | +$46,768,575 | -$14,449,845 | +$32,318,730 | GRPH, KDNY, TIL, NKTX, STRO | 13F-HR | 14 Feb 2022, 14:32 |
| Q3 2021 | 46 | $602,408,000 | +$16,791,075 | -$30,876,290 | -$14,085,215 | GRPH, NKTX, KDNY, TIL, FMTX | 13F-HR | 15 Nov 2021, 16:32 |
| Q2 2021 | 48 | $760,817,000 | +$362,073,603 | -$27,836,084 | +$334,237,519 | GRPH, NKTX, KDNY, TIL, FMTX | 13F-HR | 16 Aug 2021, 21:08 |
| Q1 2021 | 42 | $496,668,000 | +$110,285,495 | -$41,298,453 | +$68,987,042 | NKTX, KDNY, FMTX, TIL, STRO | 13F-HR | 17 May 2021, 18:06 |
| Q4 2020 | 43 | $487,389,000 | +$88,277,522 | -$80,029,966 | +$8,247,556 | NKTX, KDNY, FMTX, STRO, SYRS | 13F-HR | 16 Feb 2021, 19:12 |
| Q3 2020 | 36 | $358,514,000 | +$136,358,793 | -$79,196,466 | +$57,162,327 | FMTX, NKTX, ISEE, SWTX, CVAC | 13F-HR | 16 Nov 2020, 17:16 |
| Q2 2020 | 32 | $310,856,000 | +$122,496,740 | -$28,964,296 | +$93,532,444 | FMTX, SWTX, ODTC, PRNB, ICPT | 13F-HR | 14 Aug 2020, 16:01 |
| Q1 2020 | 28 | $173,758,000 | +$27,173,789 | -$1,699,718 | +$25,474,071 | ICPT, PRNB, SWTX, ODTC, ALLK | 13F-HR | 15 May 2020, 15:58 |
| Q4 2019 | 19 | $208,709,000 | +$21,856,087 | -$17,064,150 | +$4,791,937 | ICPT, SWTX, ALLK, ODTC, PRNB | 13F-HR | 18 Feb 2020, 12:46 |
| Q3 2019 | 18 | $146,925,000 | +$21,597,779 | -$18,209,407 | +$3,388,372 | ICPT, ALLK, SYRS, SWTX, ODTC | 13F-HR | 14 Nov 2019, 16:38 |
| Q2 2019 | 21 | $151,361,000 | +$32,137,945 | -$4,658,840 | +$27,479,105 | ICPT, ODTC, ALLK, SYRS, STRO | 13F-HR | 14 Aug 2019, 16:00 |
| Q1 2019 | 18 | $127,246,000 | +$19,140,686 | -$6,801,313 | +$12,339,373 | ICPT, ALLK, ODTC, PRNB, STRO | 13F-HR | 15 May 2019, 17:22 |
| Q4 2018 | 17 | $104,187,000 | $0 | $0 | $0 | ALLK, ICPT, PRNB, STRO, ODTC | 13F-HR | 14 Feb 2019, 16:20 |